Status:

COMPLETED

Agewise Project 3: Brief Behavioral Treatment of Insomnia in Primary Care

Lead Sponsor:

University of Pittsburgh

Collaborating Sponsors:

National Institute on Aging (NIA)

Conditions:

Insomnia

Eligibility:

All Genders

60+ years

Phase:

NA

Brief Summary

This project will test the efficacy of a brief, 2 session behavioral intervention for insomnia, as compared to an information-only condition. We hypothesize that compared to those receiving the inform...

Detailed Description

As a prevalent problem among the elderly, insomnia is often treated by primary care physicians, and benzodiazepine receptor agonists (BzRA) are the most widely prescribed form of treatment. Behavioral...

Eligibility Criteria

Inclusion

  • Age 60 or older
  • Current diagnosis of Insomnia using DSM-IV criteria (Insomnia group)
  • No current diagnosis of Insomnia (Control group)
  • Provision of written informed consent

Exclusion

  • Psychiatric: untreated depressive, anxiety, psychotic and substance use disorders and/or treated or untreated delirium of dementia. We will exclude at intake to the study any individual with moderate to severe cognitive impairment who is likely to be demented. In the event that an individual scores less than \< 25 on the Mini-Mental State Exam, we will exclude that person from the study. We will also discuss our concerns with the subject and will suggest that he or she contact the Memory Disorders Clinic run by the Alzheimer's Disease Research Center. We will give the subject literature on this Clinic as well as their phone number. We will not exclude persons with milder cognitive decrements because chronic medical disease and its associated sleep disruption are themselves associated with some impairment of cognitive performance.
  • Medical: ongoing chemotherapy or radiation cancer treatment, hospitalization within the past two weeks or terminal illness with a life expectancy less than 6 months;
  • Sleep: untreated obstructive sleep apnea syndrome, narcolepsy or restless legs syndrome.

Key Trial Info

Start Date :

June 1 2003

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2009

Estimated Enrollment :

140 Patients enrolled

Trial Details

Trial ID

NCT00177203

Start Date

June 1 2003

End Date

January 1 2009

Last Update

May 28 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Pittsburgh Medical Center, Western Psychiatric Institute & Clinic

Pittsburgh, Pennsylvania, United States, 15213